[Longterm treatment in chronic nonspecific airway diseases (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001964:Bromhexine / Q000627:therapeutic use; D001980:Bronchi / Q000378:metabolism; D001986:Bronchial Spasm / Q000188:drug therapy; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000628:therapy*; D010102:Oxygen Inhalation Therapy; D010276:Parasympatholytics / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D013256:Steroids / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000900:Anti-Bacterial Agents; D010276:Parasympatholytics; D013256:Steroids; D013806:Theophylline; D001964:Bromhexine
Langzeittherapie der chronischen unspezifischen Atemwegserkrankungen.